Clinical Trials Browser

Melanoma × In Situ Hybridization × Dermatologic × Clear all

NCT01489423 2017-05-17

Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim

Melanoma